Transcat, Inc. (NASDAQ:TRNS) Director Purchases $92,424.00 in Stock

Transcat, Inc. (NASDAQ:TRNS) Director Craig D. Cairns acquired 1,200 shares of Transcat stock in a transaction dated Friday, January 31st. The stock was purchased at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the purchase, the director now directly owns 1,910 shares in the company, valued at approximately $147,108.20. This represents a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Transcat Stock Up 0.3 %

Shares of Transcat stock traded up $0.20 on Monday, hitting $77.22. 108,401 shares of the company’s stock traded hands, compared to its average volume of 116,733. The firm’s 50-day moving average is $103.15 and its 200 day moving average is $113.80. The stock has a market cap of $710.42 million, a P/E ratio of 41.74 and a beta of 0.68. Transcat, Inc. has a 52-week low of $73.37 and a 52-week high of $147.12.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same period in the prior year, the company posted $0.56 earnings per share. Equities research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current year.

Institutional Trading of Transcat

Hedge funds and other institutional investors have recently bought and sold shares of the company. Rice Hall James & Associates LLC grew its position in shares of Transcat by 40.2% during the 4th quarter. Rice Hall James & Associates LLC now owns 35,685 shares of the scientific and technical instruments company’s stock valued at $3,773,000 after buying an additional 10,238 shares during the last quarter. Principal Financial Group Inc. boosted its stake in Transcat by 8.5% during the 4th quarter. Principal Financial Group Inc. now owns 5,002 shares of the scientific and technical instruments company’s stock valued at $529,000 after purchasing an additional 391 shares during the period. Rhumbline Advisers grew its position in Transcat by 4.1% in the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company’s stock worth $1,306,000 after purchasing an additional 486 shares during the last quarter. Catawba River Capital raised its holdings in shares of Transcat by 2.2% during the fourth quarter. Catawba River Capital now owns 67,300 shares of the scientific and technical instruments company’s stock valued at $7,116,000 after buying an additional 1,473 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its position in shares of Transcat by 23.2% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 6,477 shares of the scientific and technical instruments company’s stock worth $685,000 after buying an additional 1,219 shares during the period. 98.34% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on TRNS shares. HC Wainwright dropped their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Craig Hallum boosted their price target on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. StockNews.com upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday, January 28th. Finally, Northland Securities restated a “market perform” rating and issued a $85.00 target price (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $111.50.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.